Profile data is unavailable for this security.
About the company
Xbrane Biopharma AB, formerly Xbrane Bioscience AB, is a Sweden-based provider of biotechnology research and development services. It develops biogenerics for injectable slow release drugs and high-yield protein expression technology for the development of biosimilars. The Company's main products are Sperotide, a generic on the originator drug marketed under the trademarks Decapeptyl, Trelstar and Pamorelin, as well as Xlucane, a biosimilar on the originator drug sold under the trademark Lucentis.
- Revenue in SEK (TTM)238.73m
- Net income in SEK-322.03m
- Incorporated2008
- Employees93.00
- LocationXbrane Biopharma ABRetzius Vag 8SOLNA 171 65SwedenSWE
- Phone+46 855905600
- Websitehttps://xbrane.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Corline Biomedical AB | 25.03m | -1.81m | 224.58m | 13.00 | -- | 2.41 | -- | 8.97 | -0.0841 | -0.0841 | 1.16 | 4.34 | 0.248 | -- | 10.92 | 1,925,385.00 | -1.79 | -5.71 | -1.92 | -6.24 | 113.38 | 128.60 | -7.22 | -38.46 | -- | -89.40 | 0.00 | -- | 6.28 | 74.14 | -177.67 | -- | 62.51 | -- |
| Abliva AB | 137.00k | -95.51m | 225.05m | 6.00 | -- | 2.50 | -- | 1,642.70 | -0.0904 | -0.0904 | 0.0001 | 0.067 | 0.001 | -- | 0.0034 | -- | -70.40 | -74.59 | -80.95 | -86.98 | -14,491.24 | -- | -69,714.60 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
| SynAct Pharma AB | 0.00 | -215.81m | 236.72m | 5.00 | -- | 1.34 | -- | -- | -6.54 | -6.54 | 0.00 | 4.95 | 0.00 | -- | -- | 0.00 | -116.46 | -125.17 | -130.53 | -151.70 | -- | -- | -- | -- | -- | -- | 0.0036 | -- | -- | -- | -117.54 | -- | -- | -- |
| Ultimovacs ASA | 0.00 | -188.19m | 241.56m | 27.00 | -- | 0.8694 | -- | -- | -5.50 | -5.50 | 0.00 | 8.12 | 0.00 | -- | -- | 0.00 | -44.08 | -28.80 | -50.02 | -31.12 | -- | -- | -- | -- | -- | -- | 0.0131 | -- | -- | -- | -12.78 | -- | -45.35 | -- |
| Thor Medical ASA | 0.00 | -5.53m | 245.25m | 1.00 | -- | 0.9069 | -- | -- | -0.0318 | -0.152 | 0.00 | 1.16 | 0.00 | -- | -- | 0.00 | -2.52 | -79.17 | -2.84 | -113.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Lipum AB (publ) | 0.00 | -37.18m | 245.91m | -- | -- | 13.97 | -- | -- | -4.05 | -4.05 | 0.00 | 0.4726 | 0.00 | -- | -- | -- | -159.35 | -127.85 | -206.31 | -184.50 | -- | -- | -- | -293,228.70 | -- | -- | 0.2781 | -- | -- | -- | 2.38 | -- | -- | -- |
| Lumito AB (publ) | 0.00 | -25.80m | 255.57m | 15.00 | -- | 2.48 | -- | -- | -0.125 | -0.125 | 0.00 | 0.4997 | 0.00 | -- | -- | 0.00 | -19.98 | -20.77 | -22.14 | -22.38 | -- | -- | -- | -- | 1.42 | -- | 0.0884 | -- | -- | -- | 4.56 | -- | -- | -- |
| Aqua Bio Technology ASA | 13.44m | -1.49m | 262.74m | 2.00 | -- | 12.28 | 305.22 | 19.55 | -0.1599 | -0.1599 | 0.4938 | 0.3673 | 0.3079 | 0.6548 | 9.01 | -- | -3.42 | -80.72 | -6.75 | -125.29 | 66.69 | 5.57 | -11.12 | -965.98 | 0.1044 | 0.611 | 0.7538 | -- | 349.88 | 42.04 | 1.97 | -- | -- | -- |
| Arctic Bioscience AS | 33.56m | -45.26m | 264.91m | 20.00 | -- | 1.03 | -- | 7.89 | -1.79 | -1.79 | 1.33 | 10.19 | 0.1075 | 0.7025 | 2.93 | 1,687,501.00 | -14.50 | -- | -16.61 | -- | 28.96 | -- | -134.86 | -- | 2.53 | -- | 0.0079 | -- | -1.52 | -- | -33.77 | -- | -- | -- |
| Lytix Biopharma AS | 3.97m | -87.45m | 294.75m | -- | -- | 4.64 | -- | 74.26 | -2.16 | -2.16 | 0.0981 | 1.26 | 0.037 | -- | 0.4091 | -- | -81.63 | -57.34 | -94.30 | -66.09 | -- | -- | -2,203.36 | -4,665.04 | -- | -- | -- | -- | 183.25 | 63.94 | -57.01 | -- | -- | -- |
| Xbrane Biopharma AB | 238.73m | -322.03m | 308.96m | 93.00 | -- | 0.31 | -- | 1.29 | -1.27 | -1.52 | 0.943 | 0.6516 | 0.3553 | 2.59 | 357.65 | 2,566,979.00 | -47.92 | -40.98 | -82.48 | -67.24 | 14.82 | -- | -134.89 | -364.40 | 1.09 | -- | 0.2466 | -- | 314.33 | 63.42 | -91.10 | -- | 60.02 | -- |
| Intervacc AB | 8.02m | -102.85m | 328.70m | 15.00 | -- | 1.38 | -- | 41.01 | -1.47 | -1.47 | 0.1167 | 3.14 | 0.0306 | 3.08 | 1.72 | 534,333.30 | -39.21 | -17.62 | -42.12 | -18.77 | -628.60 | -243.59 | -1,283.24 | -626.90 | 4.38 | -- | 0.0006 | -- | -17.23 | -25.79 | -60.31 | -- | -38.72 | -- |
| Herantis Pharma Oyj | 0.00 | 3.26m | 332.20m | 10.00 | 112.57 | 6.04 | 101.94 | -- | 0.0126 | 0.0126 | 0.00 | 0.2344 | 0.00 | -- | -- | 0.00 | 4.31 | -80.46 | 6.16 | -104.37 | -- | -- | -- | -- | -- | -- | 0.0073 | -- | -- | -- | 103.00 | -- | -- | -- |
| Medivir AB | 7.73m | -96.52m | 340.22m | 10.00 | -- | 1.62 | -- | 44.00 | -1.46 | -1.46 | 0.1028 | 1.89 | 0.032 | -- | 1.56 | 773,300.00 | -40.00 | -28.91 | -47.20 | -34.77 | -888.81 | -467.42 | -1,248.18 | -675.96 | -- | -- | 0.0482 | -- | 73.16 | -20.39 | -0.6275 | -- | -47.96 | -- |
| Magle Chemoswed Holding AB | 170.01m | 12.23m | 345.60m | 78.00 | 28.26 | 2.14 | 13.79 | 2.03 | 1.13 | 1.13 | 15.74 | 14.95 | 0.6068 | 0.493 | 8.30 | 2,179,628.00 | 4.36 | 2.52 | 5.86 | 3.52 | 90.58 | 85.67 | 7.19 | 3.92 | 0.6356 | 6.35 | 0.3081 | -- | 17.00 | 9.97 | 33.07 | -- | -6.34 | -- |
| Hamlet BioPharma AB | 0.00 | -26.59m | 353.91m | 7.00 | -- | 7.82 | -- | -- | -0.207 | -0.207 | 0.00 | 0.3543 | 0.00 | -- | -- | -- | -63.29 | -83.52 | -69.05 | -107.84 | -- | -- | -- | -- | -- | -- | 0.0984 | -- | -- | -- | -18.87 | -- | 78.01 | -- |
Data as of May 03 2024. Currency figures normalised to Xbrane Biopharma AB's reporting currency: Swedish Krona SEK
3.78%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Handelsbanken Fonder ABas of 31 Mar 2024 | 24.59m | 1.62% |
| Swedbank Robur Fonder ABas of 31 Aug 2023 | 13.01m | 0.86% |
| Teknik Innovation Norden Fonder ABas of 31 Aug 2023 | 11.57m | 0.76% |
| SEB Investment Management ABas of 28 Mar 2024 | 7.60m | 0.50% |
| Storebrand Asset Management ASas of 31 Jan 2024 | 316.72k | 0.02% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 101.00k | 0.01% |
| WBS H�nicke Verm�gensverwaltung GmbHas of 31 Mar 2024 | 85.00k | 0.01% |
| Cicero Fonder ABas of 29 Feb 2024 | 56.15k | 0.00% |
| Case Kapitalf�rvaltning ABas of 30 Nov 2022 | 23.05k | 0.00% |
| Rockbridge TFIas of 30 Jun 2023 | 17.64k | 0.00% |
More ▼
Data from 30 Jun 2021 - 31 Mar 2024Source: FactSet Research Systems Inc.
